Regulatory Advice

NHSIL is focussing on high value generation from developing healthcare innovations to market. Understanding and navigating the regulatory environment is crucial from conception to clinical development. Developing and executing a regulatory strategy is a key success factor within this process.

NHSIL has successfully lead programmes to develop medicinal products and medical devices (class I -class III) from concept to pre-clinical through to clinical development.  Our diverse portfolio of projects in the various clinical arenas requires us to engage regularly with NHS R&D offices and Research Ethics Committees on a local regional basis and with national bodies such as the MHRA and NICE.

We are happy to offer our advice and share our experience with you.

For more information please contact us.